Indraprastha Medical Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indraprastha Medical Corporation Ltd. on BSE

Search Inside the pdf :

Indraprastha Medical Corporation Ltd.

28 Apr 2025

399.10

-1.03%

Company Update

Indraprastha Medical Corporation Ltd - 532150 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

we wish to inform that ICRA Limited has: a) reaffirmed long-term - fund based - cash credit rating of {ICRA}AA (pronounced ICRA Double A) for Rs. 32.50 crore and short- term - non fund based rating of {ICRA}A1+ (pronounced ICRA A One Plus) for Rs. 30 crore bank facilities: and, b) assigned long term- fund based - term loan credit rating, of {ICRA}AA (pronounced ICRA Double A) for Rs. 100 crore, to the company. This is for your information and record.

pdf

Indraprastha Medical Corporation Ltd.

28 Apr 2025

399.10

-1.03%

Corp. Note

Indraprastha Medical Corporation Ltd - 532150 - Format of the Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyIndraprastha Medical Corporation Ltd 2CIN NO.L24232DL1988PLC030958 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PRIYA RANJAN Designation: AVP CORPORATE AFFAIRS LEGAL EmailId: priya_ranjan@apollohospitals.com Name of the Chief Financial Officer: C P TYAGI Designation: CFO EmailId: tyagi@apollohospitals.com Date: 28/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Indraprastha Medical Corporation Ltd.

09 Apr 2025

399.10

-1.03%

Company Update

Indraprastha Medical Corporation Ltd - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Enclosed please find herewith, a certificate dated 02-04-2025, issued by RTA of the company for the quarter ended 31-03-2025.. this is for your information & record.

pdf

Indraprastha Medical Corporation Ltd.

24 Mar 2025

399.10

-1.03%

SAST

Indraprastha Medical Corporation Ltd - 532150 - Closure of Trading Window

BSE India

it is hereby informed that the trading window for dealing in shares of the company shall remain closed for all designated persons including promoters, directors, key managerial personnel ,designated employees and their connected persons from Tuesday, 1st April, 2025 until 48 hours after declaration of audited Financial Results by the the Company, for year ending 31st March, 2025.

pdf

Indraprastha Medical Corporation Ltd.

04 Feb 2025

399.10

-1.03%

Company Update

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

we hereby submit copies of the public notice of the financial results, published on 4th February, 2025, in the Financial express, all India Edition, in English Language and in Jansatta, Delhi edition, in Hindi language.

pdf

Indraprastha Medical Corporation Ltd.

04 Feb 2025

399.10

-1.03%

Corp. Note

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Integrated Filing (Financial)

BSE India

We are submitting herewith the Integrated Filing (Financial) for the quarter ended 31st December, 2025.

pdf

Indraprastha Medical Corporation Ltd.

03 Feb 2025

399.10

-1.03%

Result

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Unaudited Financial Results For The Quarter Ended 31St December, 2024

BSE India

The board of Director of the company has, as its meeting held on Monday, 3rd February, 2025, inter-alia, considered and approved the Un-audited Financial Results of the company for the quarter & nine months ended 31st December, 2024, along with Limited Review Report of the Statutory auditors. We are enclosing herewith un-audited financial results along with limited review report.

pdf

Indraprastha Medical Corporation Ltd.

01 Feb 2025

399.10

-1.03%

Company Update

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

we hereby submit copy of the public notice of loss of share certificates, published on 1st February, 2025, in the Financial express, Delhi edition.

pdf

Indraprastha Medical Corporation Ltd.

31 Jan 2025, 03:23PM

399.10

-1.03%

Corp. Note

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

THIS IS TO INFORM YOU THAT TH COMPANY HAS RECEIVE INTIMATION FROM THE BELOW MENTIONED SHAREHOLDER: 1. SAHIL MIGLANI, FOLIO NO- 651 NO. OF SHARES-2000 CERTIFICATE NO- 10517-10536 DISTINCTIVE NO- 54310702-54312701

pdf

Indraprastha Medical Corporation Ltd.

21 Jan 2025

399.10

-1.03%

Board Meeting

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Board Meeting To Consider And Approve …

BSE India

INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 ,inter alia, to consider and approve Meeting of the Board of the Directors of the company, will be held on Monday, 3rd February, 2025, to consider and approve the un-audited financial results for the quarter ended 31th December, 2024.

pdf

Is Indraprastha Medical Corporation Ltd. worth buying?

255 Votes:

Buy 79.61%

Sell 14.9%

Hold 5.49%

RESEARCH REPORTS

30.23% Fall from 52W High

Indraprastha Medical Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indraprastha Medical Corporation Ltd. on BSE

No research report for Indraprastha Medical Corporation Ltd.